/11<\/del><\/p>(April \u2013 December)<\/p><\/td>
2011/12<\/del><\/p><\/td>2012/13<\/del><\/p><\/td>2013/14<\/del><\/p><\/td>2014/15<\/del><\/p>(to November)<\/p><\/td><\/tr> PR and Communications staff expenditure<\/p><\/td> | £398,973.20<\/p> <\/p><\/td> | £526,784.85<\/p><\/td> | £486,320.81<\/p><\/td> | £1,066,790.92<\/p><\/td> | £1,223,775.43<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> (d) Care Quality Commission (CQC)<\/p> <\/p> <\/p> <\/p> CQC<\/p><\/td> | 2010/11<\/p><\/td> | 2011/12<\/p><\/td> | 2012/13<\/p><\/td> | 2013/14<\/p><\/td> | 2014/15<\/p> (to November)<\/p><\/td><\/tr> | PR and Communications staff expenditure<\/p><\/td> | £568,951<\/p><\/td> | £736,238<\/p><\/td> | £1,188,519<\/p><\/td> | £1,039,669<\/p><\/td> | £780,195<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> <\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2015-01-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/170098/answer/previousversion/36869", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
}
, "questionFirstAnswered" : [{"_value" : "2015-01-05T15:28:13.64Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2015-01-07T11:11:25.253Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-12-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Public Relations"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much (a) NHS England, (b) Public Health England, (c) Monitor and (d) the Care Quality Commission spent on public relations and communications staff in (i) each year since 2010 and (ii) 2014 to date.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"}
}
, "tablingMemberConstituency" : {"_value" : "Denton and Reddish"}
, "tablingMemberPrinted" : [{"_value" : "Andrew Gwynne"}
], "uin" : "218532"}
, {"_about" : "http://data.parliament.uk/resources/169515", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/169515/answer", "answerText" : {"_value" : " The regulatory bodies are independent and it is therefore for them to set their fees appropriately. All professional regulators, are aware of the Governments position, as set out in the 2011 Command Paper, `Enabling Excellence\u2019, that we would not expect registration fees to increase, unless there is a clear and strong case that any increase is essential to ensure the exercise of statutory duties.<\/p> <\/p> There are eight Healthcare Professions Regulatory Bodies (excluding the Pharmaceutical Society in Northern Ireland where responsibility is devolved to the Northern Ireland Assembly). The Department does not hold information on the fees of the regulatory bodies. However, we have obtained data from each of the regulatory bodies on the Annual Retention Fee for the last five years which shows:<\/p> <\/p> <\/p> Annual Retention Fee for Healthcare Professions Regulatory Bodies 2010-2015<\/p> <\/p> Year<\/p><\/td> | Nursing and Midwifery Council<\/p><\/td> | Health and Care Professions Council<\/p><\/td> | General Optical Council<\/p><\/td> | General Medical Council<\/p><\/td> | General Osteopathic Council<\/p><\/td> | General Pharmaceutical Council<\/p><\/td> | General Dental Council<\/p><\/td> | General Chiropractic Council<\/p><\/td><\/tr> | 2014-15<\/p><\/td> | £100<\/p><\/td> | £80<\/p><\/td> | £290<\/p><\/td> | £390<\/p><\/td> | £570<\/p><\/td> | £240<\/p><\/td> | £576<\/p><\/td> | £800<\/p><\/td><\/tr> | 2013-14<\/p><\/td> | £100<\/p><\/td> | £76<\/p><\/td> | £260<\/p><\/td> | £390<\/p><\/td> | £610<\/p><\/td> | £240<\/p><\/td> | £576<\/p><\/td> | £800<\/p><\/td><\/tr> | 2012-13<\/p><\/td> | £76<\/p><\/td> | £76<\/p><\/td> | £260<\/p><\/td> | £390<\/p><\/td> | £655<\/p><\/td> | £240<\/p><\/td> | £576<\/p><\/td> | £800<\/p><\/td><\/tr> | 2011-12<\/p><\/td> | £76<\/p><\/td> | £76<\/p><\/td> | £270<\/p><\/td> | £390<\/p><\/td> | £750<\/p><\/td> | £267<\/p><\/td> | £576<\/p><\/td> | £800<\/p><\/td><\/tr> | 2010 -11<\/p><\/td> | £76<\/p><\/td> | £76<\/p><\/td> | £280 (Dispensing optician)<\/p> £325 (Optometrist)<\/p><\/td> | £420<\/p><\/td> | £750<\/p><\/td> | £262<\/p><\/td> | £438<\/p><\/td> | £1,000<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> The Department does not hold data on the number of investigations that have been carried out by each of the healthcare professions regulatory bodies. We understand that this information is published by each of the regulatory bodies.<\/p> <\/p> The Department has five national bodies which have regulatory functions. They are the Care Quality Commission, Monitor, the Human Fertilisation and Embryology Authority, the Human Tissue Authority and the Medicines and Healthcare products Regulatory Agency. None of these bodies charge an annual registration fee but all except Monitor <\/ins>they do<\/del> receive income from a range of fees that are applied.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2014-12-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/169515/answer/previousversion/33732", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
}
, "questionFirstAnswered" : [{"_value" : "2014-12-15T17:43:27.733Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-12-18T14:09:00.283Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-12-10", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health Professions: Regulation"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what amount each of the healthcare regulators charged for annual registration fees in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1503", "label" : {"_value" : "Biography information for Mr Jamie Reed"}
}
, "tablingMemberConstituency" : {"_value" : "Copeland"}
, "tablingMemberPrinted" : [{"_value" : "Mr Jamie Reed"}
], "uin" : "218058"}
, {"_about" : "http://data.parliament.uk/resources/168663", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/168663/answer", "answerText" : {"_value" : " The Department does not <\/ins>hold this information.<\/p> <\/p> <\/p> <\/p> We take the issue of coercion seriously and staff working in abortion clinics are experienced and highly skilled in discussing sensitive issues with women and identifying whether there is any coercion or other risks to the woman.<\/p> <\/p> <\/p> <\/p> Women who present for an abortion will always have the opportunity to speak to a health professional on their own at some point during the consultation. Pathways should be in place to refer women to specialised services if coercion is identified.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-12-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/168663/answer/previousversion/33588", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
}
, "questionFirstAnswered" : [{"_value" : "2014-12-15T16:55:05.737Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-12-15T17:10:17.49Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-12-08", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Abortion"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many women were referred onwards to other care pathways after it was determined that they were being coerced into seeking an abortion in the last year for which records are available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3940", "label" : {"_value" : "Biography information for Craig Whittaker"}
}
, "tablingMemberConstituency" : {"_value" : "Calder Valley"}
, "tablingMemberPrinted" : [{"_value" : "Craig Whittaker"}
], "uin" : "217763"}
, {"_about" : "http://data.parliament.uk/resources/168664", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/168664/answer", "answerText" : {"_value" : " The Department does not <\/ins>hold this information.<\/p> <\/p> <\/p> <\/p> We take the issue of coercion seriously and staff working in abortion clinics are experienced and highly skilled in discussing sensitive issues with women and identifying whether there is any coercion or other risks to the woman.<\/p> <\/p> <\/p> <\/p> Women who present for an abortion will always have the opportunity to speak to a health professional on their own at some point during the consultation. Pathways should be in place to refer women to specialised services if coercion is identified.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-12-15", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/168664/answer/previousversion/33589", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
}
, "questionFirstAnswered" : [{"_value" : "2014-12-15T16:55:05.737Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-12-15T17:10:17.49Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-12-08", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Abortion"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many abortions were refused on the grounds on coercion in the last year for which records are available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3998", "label" : {"_value" : "Biography information for Mark Menzies"}
}
, "tablingMemberConstituency" : {"_value" : "Fylde"}
, "tablingMemberPrinted" : [{"_value" : "Mark Menzies"}
], "uin" : "217766"}
, {"_about" : "http://data.parliament.uk/resources/167080", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/167080/answer", "answerText" : {"_value" : " There are an estimated 250,000 people with the<\/ins> sickle cell trait<\/ins> anaemia<\/del> in the United Kingdom. The Department has made no estimation of the annual cost of treating sickle cell anaemia in the National Health Service nor does it hold information on the total NHS spend on sickle cell anaemia.<\/p> <\/p> <\/p> <\/p> The Department does hold estimated costs for admitted patient care episodes as reported by Healthcare Resource Groups. In 2013-14 the total estimated figure for sickle anaemia was £23.8 million; in 2012-13 it was £21.9 million. This figure does not include other costs such as primary and social care.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-12-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/167080/answer/previousversion/32239", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
}
, "questionFirstAnswered" : [{"_value" : "2014-12-08T15:12:22.95Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-12-10T16:29:44.707Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-12-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Sickle Cell Diseases"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much the NHS spends on sickle cell anaemia; and what proportion this is of the total NHS budget.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1587", "label" : {"_value" : "Biography information for Pat McFadden"}
}
, "tablingMemberConstituency" : {"_value" : "Wolverhampton South East"}
, "tablingMemberPrinted" : [{"_value" : "Mr Pat McFadden"}
], "uin" : "216527"}
, {"_about" : "http://data.parliament.uk/resources/167082", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/167082/answer", "answerText" : {"_value" : " There are an estimated 250,000 people with the<\/ins> sickle cell trait<\/ins> anaemia<\/del> in the United Kingdom. The Department has made no estimation of the annual cost of treating sickle cell anaemia in the National Health Service nor does it hold information on the total NHS spend on sickle cell anaemia.<\/p> <\/p> <\/p> <\/p> The Department does hold estimated costs for admitted patient care episodes as reported by Healthcare Resource Groups. In 2013-14 the total estimated figure for sickle anaemia was £23.8 million; in 2012-13 it was £21.9 million. This figure does not include other costs such as primary and social care.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-12-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/167082/answer/previousversion/32239", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
}
, "questionFirstAnswered" : [{"_value" : "2014-12-08T15:12:22.81Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-12-10T16:29:44.707Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-12-01", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Sickle Cell Diseases"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what estimate he has made of the annual cost to the NHS of treating sickle cell anaemia.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1587", "label" : {"_value" : "Biography information for Pat McFadden"}
}
, "tablingMemberConstituency" : {"_value" : "Wolverhampton South East"}
, "tablingMemberPrinted" : [{"_value" : "Mr Pat McFadden"}
], "uin" : "216529"}
, {"_about" : "http://data.parliament.uk/resources/105978", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/105978/answer", "answerText" : {"_value" : " The Civil Service Commission publish details of appointments made by exception and approved by them in their annual reports and on their website. These reports are available in the Library.<\/del><\/p>
It would not be appropriate to publish details of the requests turned down by the Commission as the numbers involved are small, and the individuals might be personally identified, directly or in combination with other published information.<\/del><\/p> <\/p> The Department does not operate an \u2018Instant Rewards\u2019 scheme. The Department does, however, operate an in-year bonus scheme, which has strict criteria, approval processes and budgetary control.<\/ins><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
, "dateOfAnswer" : {"_value" : "2014-11-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/105978/answer/previousversion/27280", "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"}
}
, "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"}
, "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"}
}
, "questionFirstAnswered" : [{"_value" : "2014-11-10T16:58:06.487Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-10T17:38:55.2793146Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-11-03", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pay"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how many Instant Rewards of what value were given to his Department's officials in (a) 2013 and (b) 2014 to date.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3917", "label" : {"_value" : "Biography information for Lord Walney"}
}
, "tablingMemberConstituency" : {"_value" : "Barrow and Furness"}
, "tablingMemberPrinted" : [{"_value" : "John Woodcock"}
], "uin" : "213068"}
, {"_about" : "http://data.parliament.uk/resources/100885", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100885/answer", "answerText" : {"_value" : " The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p> <\/p> <\/p> <\/p> £ million<\/em><\/p> <\/p> | <\/td> | 2009-10<\/p><\/td> | 2010-11<\/p><\/td> | 2011-12<\/p><\/td> | 2012-13<\/p><\/td> | 2013-14<\/p><\/td><\/tr> | Asthma<\/p><\/td><\/tr> | Medical Research Council<\/p><\/td> | 22.2 <\/del>6.6<\/ins><\/p><\/td>17.5 <\/del>5.3<\/ins><\/p><\/td>17.2<\/del> 4.5<\/ins><\/p><\/td>19.4<\/del> 3.6<\/ins><\/p><\/td>18.8<\/del> 5.4<\/ins><\/p><\/td><\/tr>Other Research Councils and Innovate UK<\/p><\/td> | 0.0<\/p><\/td> | 0.1<\/p><\/td> | 0.3<\/p><\/td> | 1.5<\/p><\/td> | 0.8<\/p><\/td><\/tr> | National Institute for Health Research<\/p><\/td> | 2.6<\/p><\/td> | 3.4<\/p><\/td> | 2.4<\/p><\/td> | 3.4<\/p><\/td> | 3.8<\/p><\/td><\/tr> | Total<\/p><\/td> | 24.8<\/del> 9.2<\/ins><\/p><\/td>21.0<\/del> 8.8<\/ins><\/p><\/td>19.9<\/del> 7.2<\/ins><\/p><\/td>24.3 <\/del>8.5<\/ins><\/p><\/td>23.4<\/del> 10.0<\/ins><\/p><\/td><\/tr>Motor Neurone Research<\/p><\/td><\/tr> | Medical Research Council<\/p><\/td> | 7.0<\/p><\/td> | 7.5<\/p><\/td> | 4.2<\/p><\/td> | 4.1<\/p><\/td> | 3.6<\/p><\/td><\/tr> | Other Research Councils and Innovate UK<\/p><\/td> | 0.2<\/p><\/td> | 0.2<\/p><\/td> | 0.4<\/p><\/td> | 0.7<\/p><\/td> | 1.0<\/p><\/td><\/tr> | National Institute for Health Research<\/p><\/td> | 0.1<\/p><\/td> | 0.1<\/p><\/td> | 0.4<\/p><\/td> | 0.7<\/p><\/td> | 0.5<\/p><\/td><\/tr> | Total<\/p><\/td> | 7.3<\/p><\/td> | 7.8<\/p><\/td> | 5.0<\/p><\/td> | 5.5<\/p><\/td> | 5.1<\/p><\/td><\/tr> | Osteoporosis<\/p><\/td><\/tr> | Medical Research Council<\/p><\/td> | 6.2<\/p><\/td> | 5.4<\/p><\/td> | 5.1<\/p><\/td> | 4.6<\/p><\/td> | 5.9<\/p><\/td><\/tr> | Other Research Councils and Innovate UK<\/p><\/td> | 0.0<\/p><\/td> | 0.0<\/p><\/td> | 0.1<\/p><\/td> | 0.4<\/p><\/td> | 1.0<\/p><\/td><\/tr> | National Institute for Health Research<\/p><\/td> | 0.3<\/p><\/td> | 0.7<\/p><\/td> | 0.8<\/p><\/td> | 1.3<\/p><\/td> | 1.8<\/p><\/td><\/tr> | Total<\/p><\/td> | 6.5<\/p><\/td> | 6.1<\/p><\/td> | 6.0<\/p><\/td> | 6.3<\/p><\/td> | 8.7<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p> <\/p> <\/p> <\/p> Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p> <\/p> <\/p> <\/p> Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100885/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:29.113Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Asthma: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much the Government has spent on the development of new drugs to treat the symptoms of asthma in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
}
, "tablingMemberConstituency" : {"_value" : "Leicester West"}
, "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
], "uin" : "211885"}
, {"_about" : "http://data.parliament.uk/resources/100887", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100887/answer", "answerText" : {"_value" : " The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p> <\/p> <\/p> <\/p> £ million<\/em><\/p> <\/p> | <\/td> | 2009-10<\/p><\/td> | 2010-11<\/p><\/td> | 2011-12<\/p><\/td> | 2012-13<\/p><\/td> | 2013-14<\/p><\/td><\/tr> | Asthma<\/p><\/td><\/tr> | Medical Research Council<\/p><\/td> | 22.2 <\/del>6.6<\/ins><\/p><\/td>17.5 <\/del>5.3<\/ins><\/p><\/td>17.2<\/del> 4.5<\/ins><\/p><\/td>19.4<\/del> 3.6<\/ins><\/p><\/td>18.8<\/del> 5.4<\/ins><\/p><\/td><\/tr>Other Research Councils and Innovate UK<\/p><\/td> | 0.0<\/p><\/td> | 0.1<\/p><\/td> | 0.3<\/p><\/td> | 1.5<\/p><\/td> | 0.8<\/p><\/td><\/tr> | National Institute for Health Research<\/p><\/td> | 2.6<\/p><\/td> | 3.4<\/p><\/td> | 2.4<\/p><\/td> | 3.4<\/p><\/td> | 3.8<\/p><\/td><\/tr> | Total<\/p><\/td> | 24.8<\/del> 9.2<\/ins><\/p><\/td>21.0<\/del> 8.8<\/ins><\/p><\/td>19.9<\/del> 7.2<\/ins><\/p><\/td>24.3 <\/del>8.5<\/ins><\/p><\/td>23.4<\/del> 10.0<\/ins><\/p><\/td><\/tr>Motor Neurone Research<\/p><\/td><\/tr> | Medical Research Council<\/p><\/td> | 7.0<\/p><\/td> | 7.5<\/p><\/td> | 4.2<\/p><\/td> | 4.1<\/p><\/td> | 3.6<\/p><\/td><\/tr> | Other Research Councils and Innovate UK<\/p><\/td> | 0.2<\/p><\/td> | 0.2<\/p><\/td> | 0.4<\/p><\/td> | 0.7<\/p><\/td> | 1.0<\/p><\/td><\/tr> | National Institute for Health Research<\/p><\/td> | 0.1<\/p><\/td> | 0.1<\/p><\/td> | 0.4<\/p><\/td> | 0.7<\/p><\/td> | 0.5<\/p><\/td><\/tr> | Total<\/p><\/td> | 7.3<\/p><\/td> | 7.8<\/p><\/td> | 5.0<\/p><\/td> | 5.5<\/p><\/td> | 5.1<\/p><\/td><\/tr> | Osteoporosis<\/p><\/td><\/tr> | Medical Research Council<\/p><\/td> | 6.2<\/p><\/td> | 5.4<\/p><\/td> | 5.1<\/p><\/td> | 4.6<\/p><\/td> | 5.9<\/p><\/td><\/tr> | Other Research Councils and Innovate UK<\/p><\/td> | 0.0<\/p><\/td> | 0.0<\/p><\/td> | 0.1<\/p><\/td> | 0.4<\/p><\/td> | 1.0<\/p><\/td><\/tr> | National Institute for Health Research<\/p><\/td> | 0.3<\/p><\/td> | 0.7<\/p><\/td> | 0.8<\/p><\/td> | 1.3<\/p><\/td> | 1.8<\/p><\/td><\/tr> | Total<\/p><\/td> | 6.5<\/p><\/td> | 6.1<\/p><\/td> | 6.0<\/p><\/td> | 6.3<\/p><\/td> | 8.7<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p> <\/p> <\/p> <\/p> Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p> <\/p> <\/p> <\/p> Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100887/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Asthma"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much public funding was allocated to research into asthma in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
}
, "tablingMemberConstituency" : {"_value" : "Leicester West"}
, "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
], "uin" : "211918"}
, {"_about" : "http://data.parliament.uk/resources/100721", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/100721/answer", "answerText" : {"_value" : " The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.<\/p> <\/p> <\/p> <\/p> £ million<\/em><\/p> <\/p> | <\/td> | 2009-10<\/p><\/td> | 2010-11<\/p><\/td> | 2011-12<\/p><\/td> | 2012-13<\/p><\/td> | 2013-14<\/p><\/td><\/tr> | Asthma<\/p><\/td><\/tr> | Medical Research Council<\/p><\/td> | 22.2 <\/del>6.6<\/ins><\/p><\/td>17.5 <\/del>5.3<\/ins><\/p><\/td>17.2<\/del> 4.5<\/ins><\/p><\/td>19.4<\/del> 3.6<\/ins><\/p><\/td>18.8<\/del> 5.4<\/ins><\/p><\/td><\/tr>Other Research Councils and Innovate UK<\/p><\/td> | 0.0<\/p><\/td> | 0.1<\/p><\/td> | 0.3<\/p><\/td> | 1.5<\/p><\/td> | 0.8<\/p><\/td><\/tr> | National Institute for Health Research<\/p><\/td> | 2.6<\/p><\/td> | 3.4<\/p><\/td> | 2.4<\/p><\/td> | 3.4<\/p><\/td> | 3.8<\/p><\/td><\/tr> | Total<\/p><\/td> | 24.8<\/del> 9.2<\/ins><\/p><\/td>21.0<\/del> 8.8<\/ins><\/p><\/td>19.9<\/del> 7.2<\/ins><\/p><\/td>24.3 <\/del>8.5<\/ins><\/p><\/td>23.4<\/del> 10.0<\/ins><\/p><\/td><\/tr>Motor Neurone Research<\/p><\/td><\/tr> | Medical Research Council<\/p><\/td> | 7.0<\/p><\/td> | 7.5<\/p><\/td> | 4.2<\/p><\/td> | 4.1<\/p><\/td> | 3.6<\/p><\/td><\/tr> | Other Research Councils and Innovate UK<\/p><\/td> | 0.2<\/p><\/td> | 0.2<\/p><\/td> | 0.4<\/p><\/td> | 0.7<\/p><\/td> | 1.0<\/p><\/td><\/tr> | National Institute for Health Research<\/p><\/td> | 0.1<\/p><\/td> | 0.1<\/p><\/td> | 0.4<\/p><\/td> | 0.7<\/p><\/td> | 0.5<\/p><\/td><\/tr> | Total<\/p><\/td> | 7.3<\/p><\/td> | 7.8<\/p><\/td> | 5.0<\/p><\/td> | 5.5<\/p><\/td> | 5.1<\/p><\/td><\/tr> | Osteoporosis<\/p><\/td><\/tr> | Medical Research Council<\/p><\/td> | 6.2<\/p><\/td> | 5.4<\/p><\/td> | 5.1<\/p><\/td> | 4.6<\/p><\/td> | 5.9<\/p><\/td><\/tr> | Other Research Councils and Innovate UK<\/p><\/td> | 0.0<\/p><\/td> | 0.0<\/p><\/td> | 0.1<\/p><\/td> | 0.4<\/p><\/td> | 1.0<\/p><\/td><\/tr> | National Institute for Health Research<\/p><\/td> | 0.3<\/p><\/td> | 0.7<\/p><\/td> | 0.8<\/p><\/td> | 1.3<\/p><\/td> | 1.8<\/p><\/td><\/tr> | Total<\/p><\/td> | 6.5<\/p><\/td> | 6.1<\/p><\/td> | 6.0<\/p><\/td> | 6.3<\/p><\/td> | 8.7<\/p><\/td><\/tr><\/tbody><\/table> <\/p> <\/p> <\/p> The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.<\/p> <\/p> <\/p> <\/p> Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.<\/p> <\/p> <\/p> <\/p> Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
, "dateOfAnswer" : {"_value" : "2014-10-29", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/100721/answer/previousversion/25123", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"}
}
, "answeringMemberConstituency" : {"_value" : "Mid Norfolk"}
, "answeringMemberPrinted" : {"_value" : "George Freeman"}
}
, "questionFirstAnswered" : [{"_value" : "2014-10-29T17:12:28.3318918Z", "_datatype" : "dateTime"}
], "questionFirstMinisteriallyCorrected" : [{"_value" : "2014-11-13T10:22:56.0372213Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-23", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Osteoporosis"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4026", "label" : {"_value" : "Biography information for Liz Kendall"}
}
, "tablingMemberConstituency" : {"_value" : "Leicester West"}
, "tablingMemberPrinted" : [{"_value" : "Liz Kendall"}
], "uin" : "211732"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=1&min-answer.questionFirstMinisteriallyCorrected.=2014-11-10T17%3A38%3A55.2793146Z&AnsweringBody.=Department+of+Health&max-answer.questionFirstMinisteriallyCorrected.=2015-01-07T11%3A11%3A25.253Z&max-answer.questionFirstAnswered.=2015-03-10T17%3A13%3A10.567Z", "page" : 0, "startIndex" : 1, "totalResults" : 13, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | | | |